login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ALBIREO PHARMA INC (ALBO) Stock News
USA
- NASDAQ:ALBO -
US01345P1066
-
Common Stock
44.15
USD
-0.1 (-0.23%)
Last: 3/2/2023, 8:00:01 PM
44.33
USD
+0.18 (+0.41%)
After Hours:
3/2/2023, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ALBO Latest News, Press Relases and Analysis
All
Press Releases
3 years ago - By: Benzinga
Analyst Ratings for Albireo Pharma
3 years ago - By: Albireo Pharma, Inc.
FDA Grants June 15, 2023 PDUFA Date to Albireo for Bylvay® in Alagille Syndrome
3 years ago - By: Benzinga
Cowen & Co. Downgrades Albireo Pharma: Here's What You Need To Know
3 years ago - By: Weiss Law
SHAREHOLDER ALERT: Weiss Law Investigates Albireo Pharma, Inc.
3 years ago - By: Kahn Swick & Foti, LLC
ALBIREO PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Albireo Pharma, Inc. - ALBO
3 years ago - By: The Motley Fool
- Mentions:
CINC
AZN
Why These Two Biotech Stocks Blasted Higher This Week
3 years ago - By: Seeking Alpha
Albireo Pharma (NASDAQ:ALBO) downgraded after Ipsen's proposed acquisition
3 years ago - By: Kahn Swick & Foti, LLC
ALBIREO PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Albireo Pharma, Inc. - ALBO
3 years ago - By: Seeking Alpha
- Mentions:
COIN
MARA
HUT
RIOT
...
Hot Stocks: Crypto stocks rally; CINC, ALBO soar on M&A news; LULU slumps on guidance
3 years ago - By: The Motley Fool
- Mentions:
DCT
2 Tiny Nasdaq Stocks Making Major Merger Moves Monday
3 years ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether Albireo Pharma, Inc. has obtained a Fair Price in its transaction with Ipsen
3 years ago - By: Halper Sadeh LLC
ALBO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Albireo Pharma, Inc. Is Fair to Shareholders
3 years ago - By: InvestorPlace
- Mentions:
CINC
AZN
AMYT
APGN
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Please enable JavaScript to continue using this application.